Filter News
Area of Research
- (-) Neutron Science (4)
- (-) Nuclear Science and Technology (3)
- Biological Systems (1)
- Biology and Environment (9)
- Clean Energy (6)
- Computer Science (1)
- Fusion and Fission (8)
- Fusion Energy (1)
- Materials (14)
- Materials for Computing (1)
- National Security (4)
- Quantum information Science (1)
- Supercomputing (23)
News Topics
- (-) Advanced Reactors (1)
- (-) Biomedical (1)
- (-) Frontier (1)
- (-) Nuclear Energy (4)
- (-) Quantum Science (1)
- Artificial Intelligence (1)
- Bioenergy (1)
- Biology (2)
- Clean Water (1)
- Computer Science (3)
- Cybersecurity (1)
- Decarbonization (1)
- Energy Storage (4)
- Environment (4)
- Machine Learning (1)
- Materials (3)
- Materials Science (3)
- National Security (1)
- Neutron Science (18)
- Physics (2)
- Security (1)
- Space Exploration (1)
- Summit (1)
Media Contacts
Paul Langan will join ORNL in the spring as associate laboratory director for the Biological and Environmental Systems Science Directorate.
Scientists at ORNL used neutron scattering to determine whether a specific material’s atomic structure could host a novel state of matter called a spiral spin liquid.
Jason Nattress, an Alvin M. Weinberg Fellow at the Department of Energy’s Oak Ridge National Laboratory, found his calling on a nuclear submarine.
Ask Tyler Gerczak to find a negative in working at the Department of Energy’s Oak Ridge National Laboratory, and his only complaint is the summer weather. It is not as forgiving as the summers in Pulaski, Wisconsin, his hometown.
Scientists have demonstrated a new bio-inspired material for an eco-friendly and cost-effective approach to recovering uranium from seawater.
Researchers at the Department of Energy’s Oak Ridge National Laboratory, Pacific Northwest National Laboratory and Washington State University teamed up to investigate the complex dynamics of low-water liquids that challenge nuclear waste processing at federal cleanup sites.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.